Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jun 2023 – Jul 2025Where it's discussed
-
X / Twitter27 posts
-
YouTube8 videos
AI synopsis
What people are saying
Overall, these social discussions reflect a high interest in personalized LDL management strategies, with users referencing specific research details, branding tags, and opinions that emphasize the article’s relevance. Words like 'early risk assessment' and phrases like 'must consider' showcase a tone of professional engagement and recognition of the publication's significance in advancing cardiovascular care.
Most discussions recognize the importance of personalized strategies for LDL management, aligning with the article's focus on tailored prevention methods.
The use of hashtags like #CardioTwitter and mentions of specific research sources indicate a high level of engagement and curiosity among medical professionals.
Participants reference the article's key themes, such as risk assessment and combination therapies, showing they are engaging thoughtfully with the material.
Inclusion of journal titles and calls to action like 'must consider' suggest these discussions recognize its potential influence on clinical practices.
Abstract in brief
- The text discusses how managing LDL cholesterol (LDLc) is essential for preventing atherosclerotic cardiovascular disease (ASCVD), with a focus on personalized treatment strategies guided by individual risk levels and baseline LDLc.
- It highlights the importance of using statins as the primary treatment, and considers adding nonstatin therapies for patients at very high risk, such as those with familial hypercholesterolemia, to better lower LDLc levels and prevent cardiovascular events.
- The review emphasizes moving beyond the simple primary vs secondary prevention model to a more nuanced risk continuum, advocating for early risk assessment and combination therapies in high-risk patients to improve treatment outcomes.
Top posts
Most liked on X and Blueskyhttps://t.co/9nFzaaL1c8
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum | Journal of the American Heart Association https://t.co/pXfMpCA4Tw
https://t.co/IAQ8MgBgRe #CardioTwitter #MedTwitter #CVD #Cardiology #LLT
All mentions
Effective Strategies for Lowering LDL Cholesterol and Reducing Cardiovascular Risk
Learn about current treatments, barriers, and guidelines for managing elevated LDL-C to prevent ASCVD, emphasizing shared decision-making and evidence-based practices. The videos discuss recent studies, consensus…
Understanding Normal Cholesterol Levels and Heart Disease Risks
High cholesterol is a major risk factor for heart attacks and vascular diseases. Managing cholesterol through medication, healthy habits, and exercise is essential to prevent serious cardiovascular events and maintain…
Managing Elevated LDLC to Prevent Cardiovascular Disease Risks
Elevated LDLC is directly associated with the development of ASCVD. Learn about current treatment strategies, barriers to implementing guidelines, and the importance of shared decision-making by healthcare professionals…
Identifying and Managing High-Risk Patients for ASCVD Risk
Elevated LDL cholesterol is directly linked to ASCVD development. This video discusses current treatment strategies, barriers to guideline adherence, and emphasizes shared decision-making to optimize patient care…
Assessing Intermediate Coronary Risk Using LDL Cholesterol Levels
Elevated LDL cholesterol is directly linked to the development of atherosclerotic cardiovascular disease. This video discusses current treatment barriers, strategies for prioritizing LDL management in clinical practice…
Managing Cardiovascular Disease in Adults with Elevated LDL Cholesterol
Since 1980, clinical guidelines aim to improve cardiovascular health based on scientific evidence, promoting shared decision-making and evidence-based treatments to address LDL cholesterol management effectively.
Shared Decision Making in Lipid Management and Cardiovascular Care
Explore the role of shared decision-making in managing elevated LDL cholesterol and reducing cardiovascular risk, highlighting current treatment guidelines, barriers, and strategies for effective patient-clinician…
Managing LDL Cholesterol to Prevent Cardiovascular Disease
Elevated LDL cholesterol is linked to atherosclerotic cardiovascular disease. This video discusses current treatment strategies, barriers to guideline adherence, misinformation, and the importance of shared…
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @ZHeart11768530:
RT @clinicasac: https://t.co/IAQ8MgBgRe #CardioTwitter #MedTwitter #CVD #Cardiology #LLT
RT @clinicasac: https://t.co/IAQ8MgBgRe #CardioTwitter #MedTwitter #CVD #Cardiology #LLT
RT @clinicasac: https://t.co/IAQ8MgBgRe #CardioTwitter #MedTwitter #CVD #Cardiology #LLT
https://t.co/IAQ8MgBgRe #CardioTwitter #MedTwitter #CVD #Cardiology #LLT
RT @SeguraCardio: https://t.co/9nFzaaL1c8
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum | Journal of the American Heart Association https://t.co/pXfMpCA4Tw
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum | Journal of the American Heart Association https://t.co/j1hU77vZJI
RT @SeguraCardio: https://t.co/9nFzaaL1c8
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum | Journal of the American Heart Association✅✅✅ https://t.co/CKVJOeOjKS
RT @SeguraCardio: https://t.co/9nFzaaL1c8
https://t.co/vB4gZJ24nG
RT @SeguraCardio: https://t.co/9nFzaaL1c8
RT @SeguraCardio: https://t.co/9nFzaaL1c8
https://t.co/9nFzaaL1c8
BM